Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PSC01
- Development stage
- Unknown
- Lead developer
- PersonGen BioTherapeutics
- Modality
- Gene Addition/Replacement → Gene Therapies, Gene Silencing → Gene Therapies, Gene Editing → Gene Therapies, CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
PSC01 is an investigational in vivo chimeric antigen receptor (CAR) T-cell therapy being developed by PersonGen for the treatment of B-cell malignancies. Utilizing an in vivo approach, PSC01 aims to genetically reprogram a patient's T cells to express a CAR targeting the CD19 antigen directly within the body, bypassing the need for the complex and time-consuming ex vivo manufacturing processes typical of traditional CAR-T therapies. This technology is designed to provide a more efficient and scalable treatment option for patients with CD19-positive cancers, such as B-cell lymphomas and leukemias.
- Other names
- PersonGen CD19 in vivo CAR-T
02
Targets
Beyond the preview
Go deeper on PSC01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PSC01.